A phase Ib safety and pharmacokinetic study of bavituximab plus chemotherapy in patients with refractory advanced solid tumor malignancies
Phase of Trial: Phase I
Latest Information Update: 09 Sep 2008
At a glance
- Drugs Bavituximab; Carboplatin; Docetaxel; Gemcitabine; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Peregrine Pharmaceuticals
- 09 Sep 2008 Status changed from active, no longer recruiting to completed.
- 02 Jun 2008 Results presented at the Annual Meeting of the American Society of Clinical Oncology 2008 (abstract no. 3038), according to a Peregrine Pharmaceuticals media release (9089579).
- 23 Mar 2007 Status change